EICKELMANN, Peter,MARK, Michael,SEMAN, Leo John,THOMAS, Leo,BROEDL, Uli,GREMPLER, Rolf
申请号：
DK10703288
公开号：
DK2395983T3
申请日:
2010.02.11
申请国别(地区):
DK
年份:
2020
代理人:
摘要：
The invention relates to a pharmaceutical composition according to the claim 1 comprising an SGLT2 inhibitor, a DPPIV inhibitor and a third antidiabetic agent which is suitable in the treatment or prevention of one or more conditions selected from type 1 diabetes mellitus, type 2 diabetes mellitus, impaired glucose tolerance and hyperglycemia. In addition the present invention relates to methods for preventing or treating of metabolic disorders and related conditions.
